Pregabalin Extended Release

ScieGen Pharmaceuticals, INC.🇺🇸 United States

FDA Page

Effective Date: Sep 19, 2022
Approval ID: 1544a657-353c-47f8-96ac-a63fa78373f0
Products: 3 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use PREGABALIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for . PREGABALIN extended-release tablets, for oral use, CV Initial U.S. Approval: 2004

Quick Stats

Total Products3

Labelers2

Label Sections44

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.